Código QR (código de barras bidimensional)

Exploring causes and consequences of early discontinuation of durvalumab after chemoradiotherapy for non-small cell lung cancer

Introduction: For most locally advanced non–small cell lung cancer (LA-NSCLC) patients who complete definitive chemoradiotherapy (CRT) and do not experience disease progression, one year of adjuvant durvalumab is recommended. Here, we explore causes and consequences of early durvalumab discontinuati...

Fuld beskrivelse

Na minha lista:
Principais autores: Michael Pennock, Balazs Halmos, William Bodner, Haiying Cheng, Rasim Gucalp, Nitin Ohri
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier 2023-07-01
Serier:Clinical and Translational Radiation Oncology
Fag:
Lung cancer
Immunotherapy
Radiotherapy
Durvalumab
Toxicity
Prognosis
Online adgang:http://www.sciencedirect.com/science/article/pii/S240563082300068X
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker